Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
Well known SUVs With Low Energy Utilization In 2024 vote- ‘RuPaul's Drag Race’ Season 18: How to watch without cable, premiere time, cast list and more
- Change Your Physical make-up: Compelling Activities for Muscle Building
- Guinea-Bissau's coup called a 'sham' by West African political figures
- Insurance warning signs in doctors’ offices might discourage patients from speaking openly about their health
- A Gustav Klimt painting is now the most expensive piece of modern art sold at auction. The fascinating history behind the $236 million 'Portrait of Elisabeth Lederer.'
- Explainer-What Novo Nordisk's weight-loss pill approval means for company, patients
- The Best Design Bloggers for Style Motivation
- Brilliant and Gleaming: Excellence and Skincare Practices
